Pricing Log in Create free account

GENPREX (GNPX) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

GENPREX and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. GENPREX and Purple Biotech Ltd. Sponsored ADR are of similar size ($2.0M and $1.9M). Purple Biotech Ltd. Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; GENPREX trades at 0.0×. Across the 10 metrics below, GENPREX leads on 5 and Purple Biotech Ltd. Sponsored ADR on 5.

Valuation

Metric GNPX PPBT Biotechnology median
P/E 0.03 n/m 8.50
P/S n/m n/m 9.71
P/B 0.07 0.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.89 0.16 0.64
EV/Sales n/m n/m 9.21
Earnings yield 3,170.61% (4,315.08%) (33.15%)
Free cash flow yield (1,481.72%) (643.44%) (25.50%)

Profitability

Metric GNPX PPBT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (203.86%) (110.67%) (56.36%)
Return on assets (157.40%) (100.91%) (48.04%)
Return on invested capital 0.00% (290.25%) 0.00%

Growth

Metric GNPX PPBT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 93.48% (10.14%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNPX PPBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.76 3.70 4.72
Net debt to EBITDA 0.50 0.35 0.96

Dividend

Metric GNPX PPBT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNPX PPBT Biotechnology median
Market cap 1.88m 1.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack